← Back to CUE

Cue Biopharma, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 12/05/2025
$7.9$5.7$2.1$3$0.4$3.3$2.7$1.7
−$153−$5.2−$7.4−$8.5−$12−$8.7−$10−$12
−$24.14−$1.08−$0.07−$2.67−$4.95−$0.17−$0.20−$0.25
6.34.8101515049

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.